AUPH vs JPM Stock Comparison
AUPH currently leads JPM in this stock comparison, with AIQ scores of 75 vs 65. The clearest difference is value, while JPM has the stronger risk resilience profile.
What is the main difference between AUPH and JPM?
AUPH leads the current stock comparison as Aurinia Pharmaceuticals Inc., with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Aurinia Pharmaceuticals Inc. vs JPMorgan Chase & Co.
AUPH leads
AUPH leads by 10 AIQ points, primarily on Value.
Competitive: 4 of 6 evidence groups support AUPH, and its current signal state is conflicted.
Aurinia Pharmaceuticals Inc.
JPMorgan Chase & Co.
The Algovestiq AIQ Score currently favors AUPH over JPM, 75 versus 65 as of Nov 15, 2026. AUPH's advantage is driven primarily by stronger value, while JPM holds the stronger risk resilience profile. AUPH also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor AUPH today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. AUPH lead: Stable — the AIQ differential has held near 10 points over 30 sessions.
Compare Aurinia Pharmaceuticals Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AUPH and JPM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value84 vs 10AUPH +74
- Risk Resilience68 vs 87JPM +19
- Quality77 vs 86JPM +9
- Momentum73 vs 70Even
4 of 6 evidence groups favor AUPH. AUPH’s edge is concentrated in value; JPM keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +1, not enough on its own to move the overall score.
New signals
- Price Lost 200-Day MA — bearish, trend, long horizon
- BB Lower Band Breach — bullish, volatility, short horizon
Largest factor move: Momentum +1, not enough on its own to move the overall score.
New signals
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
AUPH's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AUPH and JPM both carry a full feed there.
The central trade-off
AUPH (Aurinia Pharmaceuticals Inc.): the stronger current systematic profile, led by value.
JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, quality, technicals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
AUPHAUPH on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
AUPHAUPH on combined revenue and EPS growth.
Value
AUPHAUPH on the peer-relative Value factor, by 74 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
JPMJPM on Risk Resilience, by 19 points.
Analyst upside
AUPHAUPH on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | AUPH | JPM | Note |
|---|---|---|---|
| Implied upside to target | +14.4% | +7.8% | AUPH has more room |
| Target dispersion | 0% | +30.3% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 7 | 26 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor AUPH. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | AUPH | 75 vs 65 |
| Fundamentals | AUPH | EPS growth -17.2% vs -27.6%; TTM ROE 4.8% vs 4.1%; gross margin 90.7% vs 63.2%; operating margin 48.6% vs 28.2% |
| Valuation | AUPH | Value 84 vs 10 |
| Technicals | JPM | Price vs 50-day -4.6% vs 1.7%; vs 200-day 0% vs 6.6% |
| Risk Resilience | JPM | Risk Resilience 68 vs 87 |
| Analyst expectations | AUPH | Target upside 14.4% vs 7.8% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AUPH and JPM and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is moderate at 10 points.
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AUPH.
How the comparison changed
120 daily snapshots · May 27 – Nov 13AUPH lead: Stable — the AIQ differential has held near 10 points over 30 sessions.
- Today
- AUPH +10
- 75 vs 65
- 7 sessions ago
- AUPH +12
- 76 vs 64
- 30 sessions ago
- AUPH +10
- 73 vs 63
- 90 sessions ago
- AUPH +4
- 68 vs 64
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish, conflicted
Only AUPH
- Price Lost 200-Day MA — bearish, trend, long horizon
- BB Lower Band Breach — bullish, volatility, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
6 bullish / 1 bearish / 1 neutral, conflicted
Only JPM
- Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 1 more signal that do not separate them: Golden Cross Active.
AUPH leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.96%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1JPM closes the Value gap — currently 74 points behind, the largest single contributor to AUPH's edge.
- 2JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3AUPH's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AUPH leads on balance| Metric | AUPH | JPM |
|---|---|---|
| Revenue growth (YoY) | 0.6% | -7.6% |
| EPS growth (YoY) | -17.2% | -27.6% |
| Gross margin | 90.7% | 63.2% |
| Operating margin | 48.6% | 28.2% |
| Return on equity (TTM) | 4.8% | 4.1% |
| Debt to equity | 0.09 | 3.32 |
Performance
JPM leads 5 of 6 windows| Metric | AUPH | JPM |
|---|---|---|
| 1 week (5 sessions) | -4.4% | 3.5% |
| 1 month (20 sessions) | -4.7% | 1.9% |
| 3 months (63 sessions) | 2.9% | -4.1% |
| 6 months (126 sessions) | 2.9% | 16.2% |
| Year to date | -1.4% | 7.4% |
| 1 year (252 sessions) | 1.2% | 8% |
Technicals
JPM has the stronger structure| Metric | AUPH | JPM |
|---|---|---|
| RSI (14) | 39.9 | 56.1 |
| ADX (14) | 17.3 | 18 |
| Price vs 50-day | -4.6% | 1.7% |
| Price vs 200-day | 0% | 6.6% |
| Volatility (1M, annualized) | 36.7% | 27.4% |
Risk
JPM is the more resilient| Metric | AUPH | JPM |
|---|---|---|
| Beta | 0.64 | 0.78 |
| Sharpe ratio | 0.16 | 0.44 |
| Sortino ratio | 0.23 | 0.61 |
| Max drawdown | -21.8% | -15.5% |
| Current drawdown | -15.5% | -5.2% |
| Annualized volatility | 35.5% | 22.7% |
| Value at risk (95%) | -3.4% | -2.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AUPH or JPM?
On the Algovestiq AIQ Score, AUPH is the stronger of the two as of Nov 15, 2026, scoring 75 against JPM's 65. The edge comes from value. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AUPH or JPM the better buy right now?
AUPH carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 4 of 6 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor AUPH over JPM?
The composite weights Quality, Value, Momentum and Risk Resilience. AUPH leads Value by 74 points; JPM leads Risk Resilience by 19 points; JPM leads Quality by 9 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AUPH or JPM?
Analyst price targets imply +14.4% upside for AUPH and +7.8% for JPM, so the Street currently favors AUPH. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AUPH or JPM?
AUPH is the better-valued of the two on the peer-relative Value factor. AUPH on the peer-relative Value factor, by 74 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AUPH or JPM?
AUPH on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AUPH or JPM?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AUPH or JPM?
JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AUPH more profitable than JPM?
AUPH leads on the comparable margin measures — gross margin 90.7% vs 63.2%; operating margin 48.6% vs 28.2%; ttm roe 4.8% vs 4.1%.
Is AUPH's lead over JPM getting stronger or weaker?
AUPH lead: Stable — the AIQ differential has held near 10 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the AUPH vs JPM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Value gap — currently 74 points behind, the largest single contributor to AUPH's edge; JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; AUPH's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about AUPH and JPM?
AUPH: 2 bullish / 2 bearish, conflicted. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AUPH is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).
Compare AUPH and JPM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.